Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia van den Hoogen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Cardiovascular Translational Research|February 6, 2015
Cardiac allograft vasculopathy: a donor or recipient induced pathology?Patricia van den Hoogen, Manon M H Huibers, Joost P G Sluijter, et al.
Journal of Cardiovascular Translational Research|May 24, 2020
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future PerspectivesElise L Kessler, Martinus I F J Oerlemans, Patricia van den Hoogen, et al.
Plos One|January 1, 2020
Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Emma A Mol, et al.
Biology|January 21, 2023
Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation SurvivalPatricia van den Hoogen, Manon M H Huibers, Floor W van den Dolder, et al.
Journal of Cellular and Molecular Medicine|September 27, 2019
Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Manon M H Huibers, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Cardiovascular Translational Research|February 6, 2015
Cardiac allograft vasculopathy: a donor or recipient induced pathology?Patricia van den Hoogen, Manon M H Huibers, Joost P G Sluijter, et al.
Journal of Cardiovascular Translational Research|May 24, 2020
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future PerspectivesElise L Kessler, Martinus I F J Oerlemans, Patricia van den Hoogen, et al.
Plos One|January 1, 2020
Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Emma A Mol, et al.
Biology|January 21, 2023
Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation SurvivalPatricia van den Hoogen, Manon M H Huibers, Floor W van den Dolder, et al.
Journal of Cellular and Molecular Medicine|September 27, 2019
Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Manon M H Huibers, et al.
Pageof 1